摘要
目的 探讨不同病程对水平半规管良性阵发性位置性眩晕(horizontal canal benign paroxysmal positional vertigo,HC-BPPV)患者成功复位后残余症状的影响.方法 选取2021年7月-2022年3月上海交通大学医学院附属新华医院耳鼻咽喉头颈外科收治的HC-BPPV患者49例,根据发病至复位时间分为短病程组33例和长病程组14例.所有患者均采用转椅辅助下的Barbecue或Gufoni耳石复位治疗,成功复位后7～10 d进行复诊,复位前后均采用眩晕障碍量表(dizziness handicap inventory,DHI)进行评估,比较两组复位前后DHI各维度评分及总分差异.结果 复位前后,长病程组DHI总分均高于短病程组,差异有统计学意义(P＜0.05).复位前,长病程组DHI-F评分高于短病程组,差异有统计学意义(P＜0.05);复位后,长病程组DHI-F评分、DHI-P评分、DHI-E评分均高于短病程组,差异均有统计学意义(P＜0.05).复位前后,两组DHI各维度评分差值及总分差值比较,差异均无统计学意义(P＞0.05).结论 HC-BPPV复位后,出现残余症状的风险与复位前病程有关,病程越长,复位后出现残余症状的风险越大,残余症状可表现在躯体功能、社会功能及心理障碍等方面.
Abstract
Objective To report the effect of disease duration on residual symptoms after successful canalith repo-sitioning procedure(CRP)in patients with horizontal canal benign paroxysmal positional vertigo(HC-BPPV).Methods A total of 49 patients with primary HC-BPPV diagnosed at Xinhua Hospital Hearing and Vertigo Center from July 2021 to March 2022 were selected and divided into a short duration group(n=33)and a long duration group n=16).All pa-tients were treated with Barbecue or Gufoni maneuver assisted by a swivel chair,and were reassessed 7-10 days after successful CRP.Patients were evaluated using the Dizziness Handicap Inventory(DHI)before and after CRP,and the to-tal and sub-dimension scores were compared between the two groups.Results The total DHI score in long course group was higher than that in short course group both before and after CRP(P＜0.05).The DHI-F dimension score in long course group was higher than that in short course group before and After CRP(P＜0.05),as well as post-CRP DHI-P di-mension and DHI-E dimension scores(P＜0.05).Within each group,the pre-and post-CRP total or dimensions DHI scores showed no significant differences(P＞0.05).Conclusion The risk for residual symptoms in HC-BPPV patients af-ter CRP is related to the duration of disease,with longer course associated with greater risks.Residual symptoms may be manifested in the aspect of physical function,social function and psychology.
基金项目
国家自然科学基金(82230035)
国家自然科学基金(82271179)
上海交通大学医学院附属新华医院临床研究培育基金(21XHDB02)
维普
万方数据